147 related articles for article (PubMed ID: 28669359)
1. Radiological Growth Patterns of Prolactinomas and Nonfunctioning Adenomas.
Imran SA; Shankar J; Hebb ALO; Croul SE; Clarke DB
Can J Neurol Sci; 2017 Sep; 44(5):508-513. PubMed ID: 28669359
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT.
Pirker W; Riedl M; Luger A; Czech T; Rössler K; Asenbaum S; Angelberger P; Kornhuber J; Deecke L; Podreka I; Brücke T
J Nucl Med; 1996 Dec; 37(12):1931-7. PubMed ID: 8970508
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical, and radiological features of pituitary disease in a large MEN 1 kindred.
Burgess JR; Shepherd JJ; Parameswaran V; Hoffman L; Greenaway TM
J Clin Endocrinol Metab; 1996 Jul; 81(7):2642-6. PubMed ID: 8675591
[TBL] [Abstract][Full Text] [Related]
4. Tumor volume improves preoperative differentiation of prolactinomas and nonfunctioning pituitary adenomas.
Wright K; Lee M; Escobar N; Pacione D; Young M; Fatterpekar G; Agrawal N
Endocrine; 2021 Oct; 74(1):138-145. PubMed ID: 33966173
[TBL] [Abstract][Full Text] [Related]
5. Developing an optimal follow-up strategy based on the natural history of nonfunctioning pituitary adenomas.
Kim JH; Dho YS; Kim YH; Lee JH; Lee JH; Hong AR; Shin CS
J Neurosurg; 2018 Sep; 131(2):500-506. PubMed ID: 30215565
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of pituitary adenomas with radiological calcification.
Ogiwara T; Nagm A; Yamamoto Y; Hasegawa T; Nishikawa A; Hongo K
Acta Neurochir (Wien); 2017 Nov; 159(11):2187-2192. PubMed ID: 28825138
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and radiological geometric assessment of pituitary macroadenomas: population-based study.
Gruppetta M; Vassallo J
Clin Endocrinol (Oxf); 2016 Aug; 85(2):223-31. PubMed ID: 26998693
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Radiographic Characteristics Related to Hyperprolactinemia in Nonfunctioning Pituitary Adenomas.
Park SS; Kim JH; Kim YH; Lee JH; Dho YS; Shin CS
World Neurosurg; 2018 Nov; 119():e1035-e1040. PubMed ID: 30144593
[TBL] [Abstract][Full Text] [Related]
9. Hypopituitarism patterns among adult males with prolactinomas.
Peng J; Qiu M; Qi S; Li D; Peng Y
Clin Neurol Neurosurg; 2016 May; 144():112-8. PubMed ID: 27038873
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Microsurgical Sublabial Approach (MSA) Versus Endoscopic Endonasal Approach (EEA) for the Treatment of Pituitary Adenomas Based on Radiological and Hormonal Outcome.
Mattogno PP; Mangiola A; Lofrese G; Vigo V; Anile C
Acta Neurochir Suppl; 2017; 124():101-106. PubMed ID: 28120060
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and the prognosis of sexual dysfunction in male patients with pituitary adenomas: a multivariate analysis.
Zhou WJ; Ma SC; Zhao M; Liu C; Guan XD; Bao ZS; Jia GJ; Jia W
Asian J Androl; 2018; 20(1):43-49. PubMed ID: 28816201
[TBL] [Abstract][Full Text] [Related]
12. The Prolactin per Unit Tumor Volume Ratio Accurately Distinguishes Prolactinomas From Secondary Hyperprolactinemia due to Stalk Effect.
Faje A; Jones P; Swearingen B; Tritos NA
Endocr Pract; 2022 Jun; 28(6):572-577. PubMed ID: 35339688
[TBL] [Abstract][Full Text] [Related]
13. Relationship between expression of vascular endothelial growth factor and the proliferation of prolactinomas.
Li N; Jiang Z
Clin Neurol Neurosurg; 2017 Feb; 153():102-106. PubMed ID: 28110235
[TBL] [Abstract][Full Text] [Related]
14. Suprasellar extension independently predicts preoperative pituitary hormone deficiencies in patients with nonfunctioning pituitary macroadenomas: a single-center experience.
Margaritopoulos D; Vassiliadi DA; Markou M; Evangelatou E; Tzanela M; Tsagarakis S
Hormones (Athens); 2020 Jun; 19(2):245-251. PubMed ID: 32124257
[TBL] [Abstract][Full Text] [Related]
15. Intensity of prolactinoma on T2-weighted magnetic resonance imaging: towards another gender difference.
Kreutz J; Vroonen L; Cattin F; Petrossians P; Thiry A; Rostomyan L; Tshibanda L; Beckers A; Bonneville JF
Neuroradiology; 2015 Jul; 57(7):679-84. PubMed ID: 25845810
[TBL] [Abstract][Full Text] [Related]
16. Significance of immunohistochemical expression of Rab3B and SNAP-25 in growth hormone-producing pituitary adenomas.
Nishioka H; Haraoka J
Acta Neuropathol; 2005 Jun; 109(6):598-602. PubMed ID: 15895198
[TBL] [Abstract][Full Text] [Related]
17. Pituitary surgery and volumetric assessment of extent of resection: a paradigm shift in the use of intraoperative magnetic resonance imaging.
Serra C; Burkhardt JK; Esposito G; Bozinov O; Pangalu A; Valavanis A; Holzmann D; Schmid C; Regli L
Neurosurg Focus; 2016 Mar; 40(3):E17. PubMed ID: 26926057
[TBL] [Abstract][Full Text] [Related]
18. [Size reduction of a nonfunctioning pituitary adenoma after bromocriptine therapy: case report].
Takahashi T; Kuwayama A; Katoh T; Ichihara K; Kageyama N; Sasaki F
No Shinkei Geka; 1984 Jan; 12(1):71-80. PubMed ID: 6717737
[TBL] [Abstract][Full Text] [Related]
19. Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas.
Ferone D; Lastoria S; Colao A; Varrella P; Cerbone G; Acampa W; Merola B; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 1998 Jan; 83(1):248-52. PubMed ID: 9435450
[TBL] [Abstract][Full Text] [Related]
20. The Predictive Value of Suprasellar Extension for Visual Function Evaluation in Chinese Patients with Nonfunctioning Pituitary Adenoma with Optic Chiasm Compression.
Gan L; Ma J; Feng F; Wang Y; Cui J; Guo X; Zhang X; You H; Wang Z; Yin Z; Zhong Y; Xing B
World Neurosurg; 2018 Aug; 116():e960-e967. PubMed ID: 29857216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
